Form 4 for XFOR X4 Pharmaceuticals, Inc
Accepted 2025-08-14 00:00:00 ET · period of report 2025-08-12 · accession 0001628280-25-040441 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-08-14 | 2025-08-14 | XFOR | Craig Adam R | Executive COB, Dir | A - Grant | $0.00 | +289.9K | 289.9K | New | $0 |
| DM | 2025-08-14 | 2025-08-12+ | XFOR | Craig Adam R | Executive COB, Dir | A - Grant | $0.00 | +2.14M | 529.2K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-08-14 | A | A | 289,881 | $0.00 | 289,881 | D | — | — | (F1) Represents restricted stock units (RSUs) granted to the Reporting Person. One third of the RSUs shall vest on each of August 12, 2026, August 12, 2027 and August 12, 2028, subject to the Reporting Person continuing to provide services through each such date and contingent upon approval of the grant at the Issuer's 2026 Annual Meeting of Stockholders. |
| 2 | Derivative | Stock Option (right to buy) | 2025-08-12 | A | A | 1,609,873 | $0.00 | 1,609,873 | D | $1.42 · — to 2035-08-12 | 1,609,873 Common Stock | (F2) One third of the shares subject to the option shall vest on August 12, 2026, with the remainder vesting in equal installments each successive month thereafter for a period of 24 months, subject to the Reporting Person continuing to provide services through each such date. |
| 3 | Derivative | Stock Option (right to buy) | 2025-08-14 | A | A | 529,201 | $0.00 | 529,201 | D | $3.14 · — to 2035-08-14 | 529,201 Common Stock | (F2) One third of the shares subject to the option shall vest on August 12, 2026, with the remainder vesting in equal installments each successive month thereafter for a period of 24 months, subject to the Reporting Person continuing to provide services through each such date. |